Cargando…

Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study

BACKGROUND: When vaccines against the novel COVID-19 were available in Senegal, many questions were raised. How long should non-pharmaceutical interventions (NPIs) be maintained during vaccination roll-out? What are the best vaccination strategies? METHODS: In this study, we used an age-structured d...

Descripción completa

Detalles Bibliográficos
Autores principales: Diarra, Maryam, Kebir, Amira, Talla, Cheikh, Barry, Aliou, Faye, Joseph, Louati, Dorra, Opatowski, Lulla, Diop, Mamadou, White, Lisa J, Loucoubar, Cheikh, Miled, Slimane Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882665/
https://www.ncbi.nlm.nih.gov/pubmed/35193893
http://dx.doi.org/10.1136/bmjgh-2021-007236
_version_ 1784659746603663360
author Diarra, Maryam
Kebir, Amira
Talla, Cheikh
Barry, Aliou
Faye, Joseph
Louati, Dorra
Opatowski, Lulla
Diop, Mamadou
White, Lisa J
Loucoubar, Cheikh
Miled, Slimane Ben
author_facet Diarra, Maryam
Kebir, Amira
Talla, Cheikh
Barry, Aliou
Faye, Joseph
Louati, Dorra
Opatowski, Lulla
Diop, Mamadou
White, Lisa J
Loucoubar, Cheikh
Miled, Slimane Ben
author_sort Diarra, Maryam
collection PubMed
description BACKGROUND: When vaccines against the novel COVID-19 were available in Senegal, many questions were raised. How long should non-pharmaceutical interventions (NPIs) be maintained during vaccination roll-out? What are the best vaccination strategies? METHODS: In this study, we used an age-structured dynamic mathematical model. This model uses parameters based on SARS-CoV-2 virus, information on different types of NPIs, epidemiological and demographic data, some parameters relating to hospitalisations and vaccination in Senegal. RESULTS: In all scenarios explored, the model predicts a larger third epidemic wave of COVID-19 in terms of new cases and deaths than the previous waves. In a context of limited vaccine supply, vaccination alone will not be sufficient to control the epidemic, and the continuation of NPIs is necessary to flatten the epidemic curve. Assuming 20% of the population have been vaccinated, the optimal period to relax NPIs would be a few days from the last peak. Regarding the prioritisation of age groups to be vaccinated, the model shows that it is better to vaccinate individuals aged 5–60 years and not just the elderly (over 60 years) and those in high-risk groups. This strategy could be more cost-effective for the government, as it would reduce the high costs associated with hospitalisation. In terms of vaccine distribution, the optimal strategy would be to allocate full dose to the elderly. If vaccine doses are limited, half dose followed by full dose would be sufficient for people under 40 years because whether they receive half or full dose, the reduction in hospitalisations would be similar and their death-to-case ratio is very low. CONCLUSIONS: This study could be presented as a decision support tool to help devise strategies to control the COVID-19 pandemic and help the Ministry of Health to better manage and allocate the available vaccine doses.
format Online
Article
Text
id pubmed-8882665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88826652022-02-28 Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study Diarra, Maryam Kebir, Amira Talla, Cheikh Barry, Aliou Faye, Joseph Louati, Dorra Opatowski, Lulla Diop, Mamadou White, Lisa J Loucoubar, Cheikh Miled, Slimane Ben BMJ Glob Health Original Research BACKGROUND: When vaccines against the novel COVID-19 were available in Senegal, many questions were raised. How long should non-pharmaceutical interventions (NPIs) be maintained during vaccination roll-out? What are the best vaccination strategies? METHODS: In this study, we used an age-structured dynamic mathematical model. This model uses parameters based on SARS-CoV-2 virus, information on different types of NPIs, epidemiological and demographic data, some parameters relating to hospitalisations and vaccination in Senegal. RESULTS: In all scenarios explored, the model predicts a larger third epidemic wave of COVID-19 in terms of new cases and deaths than the previous waves. In a context of limited vaccine supply, vaccination alone will not be sufficient to control the epidemic, and the continuation of NPIs is necessary to flatten the epidemic curve. Assuming 20% of the population have been vaccinated, the optimal period to relax NPIs would be a few days from the last peak. Regarding the prioritisation of age groups to be vaccinated, the model shows that it is better to vaccinate individuals aged 5–60 years and not just the elderly (over 60 years) and those in high-risk groups. This strategy could be more cost-effective for the government, as it would reduce the high costs associated with hospitalisation. In terms of vaccine distribution, the optimal strategy would be to allocate full dose to the elderly. If vaccine doses are limited, half dose followed by full dose would be sufficient for people under 40 years because whether they receive half or full dose, the reduction in hospitalisations would be similar and their death-to-case ratio is very low. CONCLUSIONS: This study could be presented as a decision support tool to help devise strategies to control the COVID-19 pandemic and help the Ministry of Health to better manage and allocate the available vaccine doses. BMJ Publishing Group 2022-02-22 /pmc/articles/PMC8882665/ /pubmed/35193893 http://dx.doi.org/10.1136/bmjgh-2021-007236 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Diarra, Maryam
Kebir, Amira
Talla, Cheikh
Barry, Aliou
Faye, Joseph
Louati, Dorra
Opatowski, Lulla
Diop, Mamadou
White, Lisa J
Loucoubar, Cheikh
Miled, Slimane Ben
Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study
title Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study
title_full Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study
title_fullStr Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study
title_full_unstemmed Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study
title_short Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study
title_sort non-pharmaceutical interventions and covid-19 vaccination strategies in senegal: a modelling study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882665/
https://www.ncbi.nlm.nih.gov/pubmed/35193893
http://dx.doi.org/10.1136/bmjgh-2021-007236
work_keys_str_mv AT diarramaryam nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT kebiramira nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT tallacheikh nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT barryaliou nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT fayejoseph nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT louatidorra nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT opatowskilulla nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT diopmamadou nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT whitelisaj nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT loucoubarcheikh nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy
AT miledslimaneben nonpharmaceuticalinterventionsandcovid19vaccinationstrategiesinsenegalamodellingstudy